These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27680756)

  • 41. Pharmacokinetics of Intraperitoneal Daptomycin in Patients with Peritoneal Dialysis-Related Peritonitis.
    Peyro Saint Paul L; Ficheux M; Debruyne D; Loilier M; Bouvier N; Morello R; Parienti JJ; Verdon R; Fournel F; Cattoir V; Lobbedez T
    Perit Dial Int; 2017 Jan; 37(1):44-50. PubMed ID: 27680760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
    Jean SS; Lee WS; Bai KJ; Yu KW; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):290-5. PubMed ID: 25600841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ciprofloxacin in combination with other antimicrobial substances].
    Shah PM; Mellinghoff D; Stille W
    Arzneimittelforschung; 1988 Mar; 38(3):411-5. PubMed ID: 3164186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial.
    Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ
    Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of meropenem and four other antibiotics against 554 clinical strains obtained from Beijing in 1999.
    Wang H; Chen M; Xie X; Xu Y; Zhang X; Zhang Y; Yuan Y; Wang C; Liu J; Wang P
    J Infect Chemother; 2000 Sep; 6(3):178-83. PubMed ID: 11810561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Environmental superbugs: The case study of Pedobacter spp.
    Viana AT; Caetano T; Covas C; Santos T; Mendo S
    Environ Pollut; 2018 Oct; 241():1048-1055. PubMed ID: 30029312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.
    Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA
    Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of in vitro efficacy of ertapenem, imipenem and meropenem in the infections caused by the Enterobacteriaceae strains family.
    Guzek A; Tomaszewski D; Rybicki Z; Truszczyński A; Barański M; Korzeniewski K
    Anaesthesiol Intensive Ther; 2013; 45(2):67-72. PubMed ID: 23877897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meropenem-loaded Cement Is Effective in Preventing Gram-negative Osteomyelitis in an Animal Model.
    Wei J; Zhou S; Gu H; Tong K
    Clin Orthop Relat Res; 2023 Jan; 481(1):177-189. PubMed ID: 36135966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams].
    Saionji K
    Jpn J Antibiot; 1988 Oct; 41(10):1390-406. PubMed ID: 3144613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections.
    Ermertcan S; Hoşgör M; Tünger O; Coşar G
    Scand J Infect Dis; 2001; 33(11):818-21. PubMed ID: 11760161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stability of Meropenem and Piperacillin/Tazobactam with Heparin in Various Peritoneal Dialysis Solutions.
    Mendes K; Harmanjeet H; Sedeeq M; Modi A; Wanandy T; Zaidi STR; Ming LC; Castelino RL; Sud K; Peterson GM; Patel RP
    Perit Dial Int; 2018; 38(6):430-440. PubMed ID: 29991562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluids.
    Zelenitsky S; Franczuk C; Fine A; Ariano R; Harding G
    J Antimicrob Chemother; 2002 May; 49(5):863-6. PubMed ID: 12003985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
    Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model.
    Tessier PR; Nicolau DP; Onyeji CO; Nightingale CH
    Chemotherapy; 1999; 45(4):284-95. PubMed ID: 10394012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of peritoneal dialysis fluid and pH on bactericidal activity of ciprofloxacin.
    McCormick EM; Echols RM
    Antimicrob Agents Chemother; 1987 Apr; 31(4):657-9. PubMed ID: 3606070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. from Brazil.
    Kiffer CR; Kuti JL; Eagye KJ; Mendes C; Nicolau DP
    Int J Antimicrob Agents; 2006 Oct; 28(4):340-4. PubMed ID: 16930951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
    Lin G; Pankuch GA; Ednie LM; Appelbaum PC
    Antimicrob Agents Chemother; 2010 May; 54(5):2201-5. PubMed ID: 20160048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
    Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.